Rongcan Bio

About:

Rongcan Bio is a nucleic acid drug development and industrialization service provider.

Top Investors: Guangzhou Yuexiu Industrial Investment Fund, Shaanxi Investment Capital, Beijing Huafang Investment, Zhangjiagang Jintai Jinhong Investment Management

Description:

Rongcan Bio completes the nucleic acid industry chain from nucleic acid sequence design, mRNA nucleic acid raw material synthesis, delivery carrier synthesis, and final drug delivery. It is a nucleic acid drug development and industrialization service provider.

Total Funding Amount:

100M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2020-06-01

Contact Email:

rcsw(AT)rc-rna.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2023-12-06

IPO Status:

Private

Industries: